BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3341805)

  • 1. No apparent neurologic defect in a patient with xeroderma pigmentosum complementation group D.
    Ichihashi M; Yamamura K; Hiramoto T; Fujiwara Y
    Arch Dermatol; 1988 Feb; 124(2):256-60. PubMed ID: 3341805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xeroderma pigmentosum complementation group E: a case report.
    Kawada A; Satoh Y; Fujiwara Y
    Photodermatol; 1986 Aug; 3(4):233-8. PubMed ID: 3774595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed sensorineural deafness and skin carcinogenesis in a Japanese xeroderma pigmentosum group D patient.
    Mamada A; Kondo S; Kawada A; Satoh Y; Fujiwara Y
    Photodermatol; 1988 Apr; 5(2):83-91. PubMed ID: 3399439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late onset of skin cancers in 2 xeroderma pigmentosum group F siblings and a review of 30 Japanese xeroderma pigmentosum patients in groups D, E and F.
    Kondo S; Mamada A; Miyamoto C; Keong CH; Satoh Y; Fujiwara Y
    Photodermatol; 1989 Apr; 6(2):89-95. PubMed ID: 2664729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Report of three sisters with XP-E, a rare xeroderma pigmentosum complementation group.
    Fischer E; Schnyder UW; Jung EG
    Photodermatol; 1984 Oct; 1(5):232-6. PubMed ID: 6531300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assignment of two Japanese xeroderma pigmentosum patients to complementation group D and their characteristics.
    Fujiwara Y; Satoh Y
    Jpn J Cancer Res; 1985 Mar; 76(3):162-6. PubMed ID: 3922833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xeroderma pigmentosum group D patient bearing lentigo maligna without neurological symptoms.
    Fukuro S; Yamaguchi J; Mamada A; Kondo S; Satoh Y
    Dermatologica; 1990; 181(2):129-33. PubMed ID: 2242781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA repair characteristics and skin cancers of xeroderma pigmentosum patients in Japan.
    Takebe H; Miki Y; Kozuka T; Furuyama JI; Tanaka K
    Cancer Res; 1977 Feb; 37(2):490-5. PubMed ID: 832273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-related changes in photosensitivity and cellular sensitivity to ultraviolet B in a xeroderma pigmentosum group E patient.
    Kondo S; Fukuro S; Nishioka K
    Photodermatol Photoimmunol Photomed; 1991 Apr; 8(2):79-83. PubMed ID: 1756117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The determination of the complementation groups for the cells of patients with xeroderma pigmentosum and the Cockayne syndrome found in Russia].
    Pleskach NM; Mikhel'son VM; Raams A; Bootsma D
    Tsitologiia; 1996; 38(8):863-8. PubMed ID: 9027016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity to UV radiation of fibroblasts from a Japanese group A xeroderma pigmentosum patient with mild neurological abnormalities.
    Sato K; Watatani M; Ikenaga M; Kozuka T; Kitano Y; Yoshikawa K; Mimaki T; Abe J; Sugita T
    Br J Dermatol; 1987 Jan; 116(1):101-8. PubMed ID: 3814505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of xeroderma pigmentosum complementation group F with neurological abnormalities.
    Moriwaki S; Nishigori C; Imamura S; Yagi T; Takahashi C; Fujimoto N; Takebe H
    Br J Dermatol; 1993 Jan; 128(1):91-4. PubMed ID: 8427828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics, DNA repair, and complementation groups in xeroderma pigmentosum patients from Egypt.
    Hashem N; Bootsma D; Keijzer W; Greene A; Coriell L; Thomas G; Cleaver JE
    Cancer Res; 1980 Jan; 40(1):13-8. PubMed ID: 7349892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the XPD gene leading to xeroderma pigmentosum symptoms.
    Kobayashi T; Kuraoka I; Saijo M; Nakatsu Y; Tanaka A; Someda Y; Fukuro S; Tanaka K
    Hum Mutat; 1997; 9(4):322-31. PubMed ID: 9101292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [De Sanctis-Caccione syndrome: xeroderma pigmentosum with oligophrenia, short stature and neurologic disorders].
    Niederauer HH; Bohnert E; Altmeyer P; Jung EG
    Hautarzt; 1992 Jan; 43(1):25-7. PubMed ID: 1612905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cancer-free phenotype in trichothiodystrophy is unrelated to its repair defect.
    Berneburg M; Clingen PH; Harcourt SA; Lowe JE; Taylor EM; Green MH; Krutmann J; Arlett CF; Lehmann AR
    Cancer Res; 2000 Jan; 60(2):431-8. PubMed ID: 10667598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of xeroderma pigmentosum group D determined by photobiological study.
    Ishii N; Nakajima H; Kondo S; Satoh Y; Fujiwara Y; Shimoda N
    J Dermatol; 1991 Jan; 18(1):31-5. PubMed ID: 2050904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xeroderma pigmentosum group E and DDB2, a smaller subunit of damage-specific DNA binding protein: proposed classification of xeroderma pigmentosum, Cockayne syndrome, and ultraviolet-sensitive syndrome.
    Itoh T
    J Dermatol Sci; 2006 Feb; 41(2):87-96. PubMed ID: 16325378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defects in the DNA repair and transcription gene ERCC2 in the cancer-prone disorder xeroderma pigmentosum group D.
    Takayama K; Salazar EP; Lehmann A; Stefanini M; Thompson LH; Weber CA
    Cancer Res; 1995 Dec; 55(23):5656-63. PubMed ID: 7585650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A lack of radiation-induced ornithine decarboxylase activity prevents enhanced reactivation of herpes simplex virus and is linked to non-cancer proneness in xeroderma pigmentosum patients.
    Terleth C; van Laar T; Schouten R; van Steeg H; Hodemaekers H; Wormhoudt T; Cornelissen-Steijger PD; Abrahams PJ; van der Eb AJ
    Cancer Res; 1997 Oct; 57(19):4384-92. PubMed ID: 9331102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.